In the ongoing effort to determine the origins of a potentially cancer-causing impurity discovered in prescription blood pressure medications, the FDA has announced that Torrent Pharmaceuticals is expanding its own voluntary recall of its popular heart drugs. The company’s Losartan tablets tested positive for elevated levels of N-Methylnitrosobutyric acid, or NMBA, a probable human carcinogen.
The company had already issued a recall of some lots of its Losartan tablets, which are used to treat a variety of heart ailments including hypertension, but have since decided to expand it and include even more lots of the drug with expiration dates as late as 2021.
BGR Top Deals:
- Your Apple Watch will always look shiny and new with this $7 crystal clear case
- Our favorite 2-in-1 Chromebook just dropped to the lowest price of 2019
Trending Right Now:
- Leak says the Avengers might get a brand new team member
- Lyft’s massive update competes more with Google Maps than Uber
- Huge leak says next year’s iPhone 12 will feature Apple’s most massive design overhaul in a decade
FDA expands recall of blood pressure meds due to cancer-causing impurity originally appeared on BGR.com on Wed, 25 Sep 2019 at 21:03:44 EDT. Please see our terms for use of feeds.
Read more here:: Boy Genius Report